Oppenheimer Asset Management Inc. Ironwood Pharmaceuticals Inc Transaction History

Oppenheimer Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$7.8 - $16.13 $174,064 - $359,957	-22,316 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$14.31 - $17.65 $5,280 - $6,512	369 Added 1.68%	22,316 $412,000
Q2 2018 Aug 10, 2018	SELL	$11.83 - $16.2 $18,916 - $25,903	-1,599 Reduced 6.79%	21,947 $420,000
Q1 2018 May 09, 2018	BUY	$11.13 - $13.63 $1,569 - $1,921	141 Added 0.6%	23,546 $363,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $282,498 - $348,032	23,405	23,405 $369,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.